Trial Profile
Haemodynamic Effect of Dexmedetomidine in Relation to Autonomic System Activity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2021
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Pharmacodynamics
- 09 Oct 2021 Status changed from recruiting to completed.
- 10 Apr 2020 Planned End Date changed from 1 Nov 2019 to 1 Nov 2020.
- 10 Apr 2020 Planned primary completion date changed from 1 Oct 2019 to 1 Aug 2020.